TLDR
- Oscar Health stock surged 22% in premarket trading after reports that President Trump will propose a two-year extension of Affordable Care Act insurance subsidies
- Centene stock jumped nearly 10% on the same news as both companies have exposure to ACA marketplace plans
- The proposed extension includes income eligibility caps at 700% of the federal poverty line and minimum premium payment requirements
- Current ACA subsidies are set to expire at the end of 2025, which had been weighing on health insurer stocks throughout the year
- A record 24.3 million people enrolled in marketplace plans in 2025, creating urgency for subsidy extension negotiations
Oscar Health stock rocketed higher Monday morning following a weekend report about potential changes to healthcare subsidies. Politico reported late Sunday that the White House plans to propose a two-year extension for Affordable Care Act insurance subsidies.
The proposed extension sent Oscar Health shares up 22% in premarket trading. Centene, which operates as the largest plan provider on the ACA marketplaces, jumped 9.8%. Molina Healthcare rose 6%.
The White House is expected to announce a healthcare policy package soon that extends insurance premium subsidies currently set to expire at the end of the year. The proposal reportedly includes income eligibility caps to qualify for ACA tax credits and minimum premium payments.
Details of the proposal emerged Sunday evening, catching some Hill conservatives by surprise. The framework would cap subsidy eligibility at 700% of the federal poverty line according to the reports.
Oscar Health generates revenue from offering health plans through ACA exchanges. The company has exposure to marketplace plans that depend on the subsidy structure.
Centene operates as the largest marketplace plan provider. Both insurers faced pressure in 2025 as the subsidy expiration date approached.
Market Performance and Context
Health insurance stocks had struggled throughout 2025 due to subsidy uncertainty. Centene declined 40% through Friday’s close while Molina dropped 51%. Oscar Health had gained less than 1% during the same period.
The subsidy extension addresses concerns about 2026 premium increases. A record 24.3 million people enrolled in marketplace plans for 2025.
Without the extension, millions of enrollees were expected to drop coverage. The higher premiums would have made insurance unaffordable for many marketplace participants.
Senator Maggie Hassan commented that the proposal represents a starting point for negotiations. Lawmaker reactions remain mixed as additional details continue to emerge.
Republicans in Congress had been waiting for the President’s position on healthcare policy. The announcement provides direction for legislative discussions.
Wall Street Response
Analysts maintain a cautious outlook on Oscar Health despite the premarket rally. The current consensus rating sits at “moderate sell” with an average price target of $12.33.
Oscar Health closed a recent session down over 17% before the subsidy news emerged. The stock rebounded in after-hours trading as speculation about federal healthcare policy intensified.
The company announced expansion plans including AI-powered health tools for the 2026 enrollment period. These initiatives focus on innovation and geographic growth.
Other marketplace participants may see trading volatility based on policy developments. Near-term price action depends on White House announcements and congressional negotiations.
MS NOW indicated Trump could announce the healthcare framework as early as Monday. The proposed subsidy extension would provide market stability for insurers operating in the ACA marketplace.
The higher income cap at 700% of the federal poverty line could expand the addressable market. This expansion would benefit companies specializing in individual health plans sold through the exchanges.


